News
Recent news about Panacea Capital and select portfolio companies
Why Australia & New Zealand Are Smart Alternatives for Your Clinical Trial During FDA Uncertainty
Navigating the Next Few Years with Confidence 2025 has been marked by significant regulatory…
Why Australia & New Zealand Are Smart Alternatives for Your Clinical Trial During FDA Uncertainty
Navigating the Next Few Years with Confidence 2025 has been marked by significant regulatory…
Navigating Clinical Trials in the Philippines and Malaysia: Insights and Opportunities
Due to a combination of large, diverse populations, effective healthcare infrastructure, and evolving regulatory and…
Navigating Clinical Trials in the Philippines and Malaysia: Insights and Opportunities
Due to a combination of large, diverse populations, effective healthcare infrastructure, and evolving regulatory and…
Drug Discovery World – JPM 2026: Less talk and more action
Drug Discovery World – JPM 2026: Less talk and more action
Understanding the US FDA’s Special Designations and Approval Pathways
Recognizing the challenges of drug development, the US FDA has established several special designations and…
Understanding the US FDA’s Special Designations and Approval Pathways
Recognizing the challenges of drug development, the US FDA has established several special designations and…
Maximizing Global Study Value: Clinical Trial Landscapes in South Korea and Japan
Clinical trial globalization continues to be a major trend for industry-sponsored clinical trials. More recently,…
Maximizing Global Study Value: Clinical Trial Landscapes in South Korea and Japan
Clinical trial globalization continues to be a major trend for industry-sponsored clinical trials. More recently,…